Comorbidity of depression and anxiety in the elderly

被引:63
作者
Eric J. Lenze
机构
[1] Intervention Res. Ctr. in Late-life, Department of Psychiatry, Univ. of Pittsburgh Sch. of Medicine, Pittsburgh, PA 15213
关键词
Anxiety Disorder; Anxiety Symptom; Reboxetine; Geriatr Psychiatry; Comorbid Anxiety;
D O I
10.1007/s11920-003-0011-7
中图分类号
学科分类号
摘要
Elderly patients with depression commonly suffer from concurrent symptoms of anxiety or comorbid anxiety disorders. Such comorbidity is associated with a more severe presentation of depressive illness, including greater suicidality. Additionally, most antidepressant treatment studies of elderly individuals with depression have found poorer treatment outcomes in those with comorbid anxiety, for example, delayed or diminished response and increased likelihood of dropout from treatment. In terms of treatment of anxious depression, there is evidence that tricyclic antidepressants and serotonin reuptake inhibitors are not different from each other in terms of efficacy or tolerability. Rather than the specific choice of antidepressant medication, it appears that quality of clinical management has the greatest impact on likelihood of remission in anxious depressed elderly individuals. Co-prescription of benzodiazepines is sometimes warranted for severe anxiety, but increases the risk of cognitive or motor impairment. Psychotherapy, including cognitive-behavioral therapy and interpersonal therapy, which are efficacious for late-life depression in general, should also be considered for treatment alone or in combination with appropriate medication. Future research areas are also addressed in this paper. Copyright © 2003 by Current Science Inc.
引用
收藏
页码:62 / 67
页数:5
相关论文
共 61 条
[1]  
Parmelee P., Katz I., Lawton M.P., Anxiety and its association with depression among institutionalized elderly, Am. J. Geriatr. Psychiatry, 1, pp. 65-78, (1993)
[2]  
Beekman A.T., de Beurs E., van Balkom A.J., Et al., Anxiety and depression in later life: Co-occurrence and communality of risk factors, Am. J. Psychiatry, 157, pp. 89-95, (2000)
[3]  
Lenze E.J., Mulsant B.H., Shear M.K., Et al., Comorbid anxiety disorders in depressed elderly patients, Am. J. Psychiatry, 157, pp. 722-728, (2000)
[4]  
Burvill P.W., Johnson G.A., Jamrozik K.D., Et al., Anxiety disorders after stroke: Results from the Perth Community Stroke Study, Br. J. Psychiatry, 166, pp. 328-332, (1995)
[5]  
Beekman A.T., Bremmer M.A., Deeg D.J., Et al., Anxiety disorders in later life: A report from the Longitudinal Aging Study Amsterdam, Int. J. Geriatr. Psyciatry, 13, pp. 717-726, (1998)
[6]  
Flint A.J., Epidemiology and comorbidity of anxiety disorders in the elderly, Am. J. Psychiatry, 151, pp. 640-649, (1994)
[7]  
Lyketsos C.G., Steinberg M., Tschanz J.T., Mental and behavioral disturbances in dementia: Findings from the Cache County study on memory in aging, Am. J. Psychiatry, 157, pp. 708-714, (2000)
[8]  
Schweizer E., Rickels K., Benzodiazepine dependence and withdrawal: A review of the syndrome and its clinical management, Acta Psychiatr. Scand., 98, SUPPL., pp. 95-101, (1998)
[9]  
Gleason P.P., Schulz R., Smith N.L., Et al., Correlates and prevalence of benzodiazepine use in community-dwelling elderly, J. Gen. Intern. Med., 13, pp. 243-250, (1998)
[10]  
Rollman B.L., Block M.R., Schulberg H.C., Major depression and tricyclic side effects in primary care patients, J. Gen. Intern. Med., 12, pp. 284-291, (1997)